HPR38 Review of NICE, PBAC, and CDA HTA Outcomes For Oncology Drugs Approved by the FDA Through Project Orbis (2022-2023)

20250 citationsJournal Article

Authors

Partnerships for the goals

Published in: Value in Health

Volume 28, Issue 6, pp. S201-S201

Field-Weighted Citation Impact: 0.00